Tag
Albumin-Carrier-Therapie
2025
-
Ivermectin nanoparticles shrink glioblastomas by 70 %
According to a study from Brazil, ivermectin nanoparticles destroy brain tumour cells in rats: tumours shrink by 70 %. A promising approach for new cancer therapies?
2024
-
Autarkie & Me • Episode 10 • Albumin Carrier Therapy
Radio SOL and GAIA on "ACT – albumin carrier therapy against cancer" – the 10th episode of the series "Autarkie & Me" was broadcast on 20.11.2024. Guest: Michael Denck
-
Cancer: more and more young people affected
Doctors are baffled by the rising trend of cancer diagnoses in adults in the prime of life. We provide information on ACT (albumin carrier therapy)
2022
-
Albumin carrier therapy with methotrexate (MTX-HSA)
A well-tolerated therapy component for advanced tumour diseases with antiproliferative, anti-inflammatory and immunomodulatory effects.
-
Albumin carrier therapy | Case studies
Albumin is the most common protein in the human organism. It has a half-life of 19 days and is responsible for many transport functions in the body.
-
Albumin carrier therapy | Against cancer
Albumin carrier therapy is a low-side-effect treatment for tumours, metastases and inflammation: the active substance is coupled to albumin and carried directly into the tumour cells.